Objective-(1) To measure objectively the subjective improvement in joint stiVness following intra-articular injections of corticosteroids, and (2) to record changes in joint stiVness in the first 24 hours after injection to look for changes in the physical properties of the joint that would be consistent with a crystal synovitis. Methods-The study population consisted of 15 patients having 17 metacarpophalangeal joints injected as part of their routine care. Measurements were taken before injection, at 24 hours, and after one week. Outcome variables included articular stiVness, strength, joint range of movement, and subjective scores. 
; curve area from 0.1003 to 0.1555 units), but the increase was not significant. After one week a significant decrease in "elastic stiVness" had occurred (mean slope from 0.0085 to 0.0065 Nm degree Intra-articular corticosteroids are widely used to control synovial inflammation in inflammatory arthritis. Their beneficial action is apparent after 24-48 hours and may last for several months, depending on the preparation used.
1 Adverse eVects are few; Hollander has reported minor side eVects in 1-2% and infrequent major adverse events (for example, joint sepsis): 19 cases in over 400 000 injections. 2 However, some patients do complain of an initial deterioration in symptoms, usually within the first 12-24 hours. Hollander ascribed this to a transient crystal synovitis induced by the micro-crystalline corticosteroid preparations.
Indeed, the size of some corticosteroid preparations is very similar to that of monosodium urate crystals (for example, triamcinolone hexacetonide in Lederspan is 20-100 microns; urate crystals are 5-20 microns). McCarty and Hogan have found evidence of crystal synovitis (as indicated by a leucocyte-rich synovial aspirate) following intrasynovial injection of corticosteroids in normal volunteers. 3 Objective measures of joint stiVness are not widely used in clinical practice despite the almost universal use of "duration of early morning stiVness" as an outcome measure in clinical trails on patients with inflammatory arthritis. Early devices were cumbersome 4 and later computer driven devices appeared to be unable to record the subjective increases in stiVness. 5 6 Further work has shown, however, that providing allowance is made for finger circumference and forearm muscle bulk, comparative changes in joint stiVness can be made. 7 The aims of this study were (1) to measure objectively the subjective improvement in joint stiVness following intra-articular injections of corticosteroids, and (2) to record changes in joint stiVness in the first 24 hours after injection to look for changes in the physical properties of the joint that would be consistent with a crystal synovitis.
Methods
Inpatients with inflammatory arthritis requiring an intra-articular injection of corticosteroid into the third metacarpophalangeal (McP3) joint were invited to participate in the study. Basic demographic and disease details were obtained and the following measurements taken. Grip and pinch strength were measured with an electronic strain gauge dynamometer (MIE Medical Research, Leeds). 8 Range of movement in the metacarpophalangeal joint was measured with a simple metallic angle goniometer using passive pressure to reach the end range. Subjective assessment of pain and stiVness was made using graduated plastic scales 100 mm long marked "no pain" (or stiVness) at one end and "worse pain ever" (or stiVness) at the other. StiVness was measured with the Leeds microprocessor controlled arthrograph. 9 This device imparts small (8°) sinusoidal movements to the relaxed metacarpophalangeal joint and measures resistance to movement with strain gauges bonded to the movement arm. Several cycles are averaged to produce a hysteresis curve from journal Annals of the Rheumatic Diseases 1997;56:71-73 which measures of joint stiVness can be obtained: "elasticity" represents the recoverable energy of deformation (modelled as a rubber band) and "viscosity" the non-recoverable energy (modelled as a piston in a cylinder of viscous fluid). All measurements were made immediately before joint injection, at 24 hours postinjection, and at one week postinjection. In one case more frequent measurements were made over the first 24 hours after injection.
Injections into the McP3 joint were made by the author using the dorsal approach with the finger in light traction. All cases were injected with triamcinolone hexacetonide. The maximum volume injected did not exceed 0.5 ml. Other treatments such as physiotherapy were not applied to the injected hand during the study.
Results
Seventeen metacarpophalangeal joints were injected in 15 patients (mean age, 61 years; 10 females, five males). The majority of patients had rheumatoid arthritis, two had psoriatic arthritis. The mean disease duration was 14.1 years (range 0.5 to 36 years), mean Ritchie articular index 16.7 (6 to 28), and mean Larsen score for hands was 64.2 (24 to 113).
The results are summarised in the table. Overall there was a trend for stiVness variables to deteriorate 24 hours after injection but to improve by the end of the week. Significant changes in elastic stiVness, maximum grip, range of movement, and subjective scores were seen between baseline and 1 week.
Individual changes in elastic stiVness, expressed as the standard normal deviate [z = (x i −x fl)/s] are depicted graphically in the figure. Eight patients deteriorated objectively at 24 hours (subjectively only two patients complained of a worsening of pain and four patients complained of a deterioration in stiVness). After seven days, 12 joints had improved, four had deteriorated, and one was unchanged (after being worse at 24 hours). The two groups of patients (those who deteriorated and those who improved at 24 hours) were similar with respect to age, duration of disease, Ritchie articular index, Larsen score, range of movement, and joint stiVness, but differed with respect to erythrocyte sedimentation rate (deteriorate v improve: mean ESR 21 v 41, t = −2.55, P = 0.03).
In one patient recordings were made at four hourly intervals for the first 24 hours. No increase in stiVness was seen at four hours but by eight hours an increase had occurred.
Discussion
Intra-articular steroids are given to suppress inflammation locally. The reduction of inflammatory mediators results in less periarticular oedema, less joint eVusion, and less pain, and there is a corresponding improvement in mechanical symptoms such as range of movement and stiVness. A device such as the arthrograph permits an objective assessment of the symptom of stiVness and allows serial measurements of the mechanical properties of a joint in response to therapeutic interventions such as intra-articular steroid injections. The arthrograph may be of more limited use in recording serial changes in joint stiVness over longer periods of time (years) since the absolute measure of stiVness depends on a number of factors including the degree of joint damage 5 and associated muscle wasting. 7 However, in situations where joint stiVness is changing rapidly due to a reduction in local inflammation in response to treatment, the arthrograph can provide a truly objective measure of joint mechanics. In this study the expected decrease in joint stiVness was found one week after injection and this was accompanied by a corresponding decrease in subjective stiVness and pain.
However, an increase in joint stiVness at 24 hours occurred in eight joints (eight patients). Half the patients were unaware of Individual changes in elastic stiVness (see text for explanation of z score). Firstly, do subjective and objective assessments not match because they are measuring diVerent things? The engineers' definition of stiVness (an increase in resistance to movement) matches that of the physician and has recently been shown to match that of the patient. 10 Secondly, do patients perhaps tell us only what they think we want to hear? Thus in the face of a worsening (or at least a non-improvement) in their symptoms at 24 hours are they reluctant to admit this to the physician when improvement should be occurring? Thirdly, there may be a threshold eVect so that a certain percentage change in stiVness must occur before it will be appreciated: of the patients who felt a deterioration, the mean increase in joint stiVness was 46.9%, compared to 17.4% in the patients who did not feel this change. Fourthly, people may diVer in their sensitivity to changes in stiVness, as with others forms of sensation.
The volume of fluid injected at the time of intra-articular treatment is limited by the size of the joint. For the metacarpophalangeal joint the maximum injectable volume is 0.5-1 ml; using these volumes the joint capsule will be distended and patients report this feeling of distension and increased stiVness immediately after joint injection. However, this quickly subsides. In order to avoid any eVect of joint distension associated with intra-articular injections, stiVness measurements were made 24 hours after injection. In the patient in whom more frequent early measurements were made no change was seen at four hours but by eight hours an increase had occurred. In this patient at least this was not simply due to an increase in intracapsular volume.
Hollander suggested that some degree of crystal synovitis is universal following intraarticular injection of crystalline steroids. 2 This would accord with what is known of the particle size of these preparations compared to, for example, uric acid crystals, although in practice it would be diYcult to distinguish between crystal synovitis and chemical synovitis resulting from preservatives in the steroid preparation. Uric acid crystals are avidly phagocytosed (with subsequent cell death) when they occur free in synovial fluid and it seems likely that the same process may occur with steroid crystals. The subsequent cell rupture and release of lysosomal enzymes is responsible for the acute synovitis of gout but with steroid crystals the profound antiinflammatory eVect of the steroid preparation probably prevents a marked deterioration in the synovitis and the appearance of overt inflammation in the injected joint. Nevertheless, the results of this study suggest that in some patients there may be a brief increase in joint inflammation following intra-articular steroids: this may be due to the crystalline nature of the preparation or to chemical preservatives contained therein.
